Open-Label Phase-Ii-Study For Evaluating The Efficacy And Safety Of Domatinostat In Combination With Avelumab In Advanced, Unresectable/Metastatic Merkel Cell Carcinoma Patients With Progression Under Anti-Pd-(L) 1-Antibody Therapy - The Merklin 2 Study
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要